Jazz Pharmaceuticals (JAZZ) Finished Goods (2010 - 2019)

Jazz Pharmaceuticals' Finished Goods history runs 10 years deep, the most recent figure standing at $22.3 million for Q1 2019.

• In Q1 2019, Finished Goods changed N/A year-over-year to $22.3 million; the TTM figure through Mar 2019 stood at $22.3 million (changed N/A YoY), while the FY2018 annual figure was $21.3 million, down 11.22% from the prior year.
• Finished Goods was $22.3 million for Q1 2019 at Jazz Pharmaceuticals, up from $21.3 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $24.0 million in Q4 2017 to a low of $5.0 million in Q4 2015.
• Historically, Finished Goods has averaged $16.0 million across 5 years, with a median of $17.9 million in 2018.
• The sharpest annual moves came in 2015 and 2016: Finished Goods slumped 69.83% in 2015, then soared 175.91% in 2016.
• A 5-year view of Finished Goods shows it stood at $5.0 million in 2015, then jumped by 175.91% to $13.8 million in 2016, then surged by 73.8% to $24.0 million in 2017, then dropped by 11.22% to $21.3 million in 2018, then rose by 4.68% to $22.3 million in 2019.
• The last three Finished Goods figures came in at $22.3 million (Q1 2019), $21.3 million (Q4 2018), and $17.9 million (Q2 2018), per Business Quant data.